• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心率和收缩压联合风险分层在慢性心力衰竭管理中的作用。来自 CHART-2 研究的报告。

Usefulness of combined risk stratification with heart rate and systolic blood pressure in the management of chronic heart failure. A report from the CHART-2 study.

机构信息

Departments of Cardiovascular Medicine and Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine.

出版信息

Circ J. 2013;77(12):2954-62. doi: 10.1253/circj.cj-13-0725. Epub 2013 Oct 1.

DOI:10.1253/circj.cj-13-0725
PMID:24088306
Abstract

BACKGROUND

The appropriate target ranges of heart rate (HR) and systolic blood pressure (SBP) for the management of chronic heart failure (CHF) patients remain to be elucidated in a large-scale cohort study.

METHODS AND RESULTS

We examined 3,029 consecutive CHF patients with sinus rhythm (SR) (mean age, 67.9 years) registered in the Chronic Heart Failure Analysis and Registry in the Tohoku District-2 Study (CHART-2; NCT00418041). There were 357 deaths (11.8%) during the median follow-up of 3.1 years. We first performed the classification and regression tree analysis for mortality, identifying SBP <89 mmHg, HR >70 beats/min and SBP <115 mmHg as the primary, secondary and tertiary discriminators, respectively. According to these, we divided the patients into low- (n=1,131), middle- (n=1,624) and high-risk (n=274) groups with mortality risk <10%, 10-20% and >20%, respectively. The low-risk group was characterized by SBP >115 mmHg and HR <70 beats/min and the high-risk group by SBP <89 mmHg regardless of HR values or SBP 89-115 mmHg and HR >76 beats/min. Multivariate Cox regression analysis revealed that the hazard ratio of all-cause death for low-, middle- and high-risk groups was 1.00 (reference), 1.48 (95% confidence interval (CI): 1.10-1.99, P=0.009) and 2.44 (95% CI 1.66-3.58, P<0.001), respectively. Subgroup analysis revealed that age ≥70 years, diabetes, or reduced left ventricular function had higher hazard ratios in the high-risk group.

CONCLUSIONS

The results demonstrate the usefulness of combined risk stratification of HR and SBP in CHF patients with SR.

摘要

背景

在大规模队列研究中,仍需要阐明适合慢性心力衰竭(CHF)患者管理的心率(HR)和收缩压(SBP)的适当目标范围。

方法和结果

我们检查了在东北区-2 研究(CHART-2;NCT00418041)中注册的 3029 例窦性节律(SR)连续 CHF 患者(平均年龄 67.9 岁)。在中位数为 3.1 年的随访期间,有 357 例死亡(11.8%)。我们首先对死亡率进行了分类和回归树分析,确定 SBP<89mmHg、HR>70 次/分和 SBP<115mmHg 分别为主要、次要和三级鉴别指标。根据这些指标,我们将患者分为低危(n=1131)、中危(n=1624)和高危(n=274)组,死亡率风险分别<10%、10-20%和>20%。低危组的特征是 SBP>115mmHg 和 HR<70 次/分,高危组的特征是无论 HR 值或 SBP 为 89-115mmHg 和 HR>76 次/分,SBP<89mmHg。多变量 Cox 回归分析显示,低危、中危和高危组全因死亡的危险比分别为 1.00(参考)、1.48(95%置信区间(CI):1.10-1.99,P=0.009)和 2.44(95%CI 1.66-3.58,P<0.001)。亚组分析显示,年龄≥70 岁、糖尿病或左心室功能降低的高危组具有更高的危险比。

结论

结果表明,在 SR 的 CHF 患者中,HR 和 SBP 的联合风险分层具有一定的实用性。

相似文献

1
Usefulness of combined risk stratification with heart rate and systolic blood pressure in the management of chronic heart failure. A report from the CHART-2 study.心率和收缩压联合风险分层在慢性心力衰竭管理中的作用。来自 CHART-2 研究的报告。
Circ J. 2013;77(12):2954-62. doi: 10.1253/circj.cj-13-0725. Epub 2013 Oct 1.
2
Combining heart rate and systolic blood pressure to improve risk stratification in older patients with heart failure: Findings from the RICA Registry.结合心率和收缩压以改善老年心力衰竭患者的风险分层:RICA注册研究结果
Int J Cardiol. 2017 Mar 1;230:625-629. doi: 10.1016/j.ijcard.2016.12.041. Epub 2016 Dec 27.
3
Usefulness of systolic blood pressure combined with heart rate measured on admission to identify 1-year all-cause mortality risk in elderly patients firstly hospitalized due to acute heart failure.评估因急性心力衰竭初次住院的老年患者入院时收缩压与心率联合检测对 1 年全因死亡率风险的预测价值。
Aging Clin Exp Res. 2020 Jan;32(1):99-106. doi: 10.1007/s40520-019-01153-2. Epub 2019 Feb 21.
4
Prognostic value of long-term blood pressure changes in patients with chronic heart failure.慢性心力衰竭患者长期血压变化的预后价值。
Eur J Heart Fail. 2017 Jul;19(7):837-842. doi: 10.1002/ejhf.805. Epub 2017 Mar 27.
5
Systolic blood pressure and mortality in patients with atrial fibrillation and heart failure: insights from the AFFIRM and AF-CHF studies.心房颤动和心力衰竭患者的收缩压与死亡率:来自 AFFIRM 和 AF-CHF 研究的结果。
Eur J Heart Fail. 2014 Nov;16(11):1168-74. doi: 10.1002/ejhf.168. Epub 2014 Oct 9.
6
Prognostic Significance of Low Systolic Blood Pressure at Discharge in Patients with Heart Failure and Preserved Ejection Fraction.射血分数保留的心力衰竭患者出院时低收缩压的预后意义
High Blood Press Cardiovasc Prev. 2017 Dec;24(4):405-412. doi: 10.1007/s40292-017-0223-2. Epub 2017 Jul 19.
7
Prognostic value of daytime heart rate, blood pressure, their products and quotients in chronic heart failure.心率、血压及其乘积和商在慢性心力衰竭中的预后价值。
Cardiol J. 2019;26(1):20-28. doi: 10.5603/CJ.a2017.0130. Epub 2017 Nov 13.
8
Relation of Systolic Blood Pressure on the Following Day with Post-Discharge Mortality in Hospitalized Heart Failure Patients with Preserved Ejection Fraction.射血分数保留的住院心力衰竭患者次日收缩压与出院后死亡率的关系。
Int Heart J. 2019 Jul 27;60(4):876-885. doi: 10.1536/ihj.18-699. Epub 2019 Jun 28.
9
Systolic blood pressure response to exercise as a predictor of mortality in patients with chronic heart failure.
Int Heart J. 2010 Mar;51(2):111-5. doi: 10.1536/ihj.51.111.
10
Is heart rate important for patients with heart failure in atrial fibrillation?心率对于房颤合并心力衰竭患者重要吗?
JACC Heart Fail. 2014 Jun;2(3):213-20. doi: 10.1016/j.jchf.2014.01.005. Epub 2014 Apr 30.

引用本文的文献

1
Efficacy of ivabradine in heart failure patients with a high-risk profile (analysis from the SHIFT trial).依伐布雷定治疗高危心力衰竭患者的疗效(SHIFT 试验分析)。
ESC Heart Fail. 2023 Oct;10(5):2895-2902. doi: 10.1002/ehf2.14455. Epub 2023 Jul 10.
2
Genome Editing and Pathological Cardiac Hypertrophy.基因组编辑与病理性心肌肥厚
Adv Exp Med Biol. 2023;1396:87-101. doi: 10.1007/978-981-19-5642-3_6.
3
Utilization and Efficacy of Cardiac Resynchronization Therapy in Patients With Chronic Heart Failure - A Report From the CHART-2 Study.
慢性心力衰竭患者心脏再同步治疗的应用与疗效——CHART-2研究报告
Circ Rep. 2022 May 25;4(6):264-273. doi: 10.1253/circrep.CR-22-0036. eCollection 2022 Jun 10.
4
Differences in the prognoses of patients referred to an advanced heart failure center from hospitals with different bed volumes.不同床位数医院转诊至心力衰竭中心患者的预后差异。
Sci Rep. 2020 Dec 3;10(1):21071. doi: 10.1038/s41598-020-78162-z.
5
Clinical characteristics and prognostic factors in elderly patients with chronic heart failure -A report from the CHART-2 study.老年慢性心力衰竭患者的临床特征及预后因素——CHART-2研究报告
Int J Cardiol Heart Vasc. 2020 Mar 20;27:100497. doi: 10.1016/j.ijcha.2020.100497. eCollection 2020 Apr.
6
Application of self-care based on full-course individualized health education in patients with chronic heart failure and its influencing factors.全程个体化健康教育的自我护理在慢性心力衰竭患者中的应用及其影响因素。
World J Clin Cases. 2019 Aug 26;7(16):2165-2175. doi: 10.12998/wjcc.v7.i16.2165.
7
Hemodynamic, management, and outcomes of patients admitted to emergency department with heart failure.因心力衰竭入住急诊科患者的血流动力学、管理及预后
Scand J Trauma Resusc Emerg Med. 2016 Nov 7;24(1):132. doi: 10.1186/s13049-016-0324-2.
8
Association of resting heart rate and hypertension stages on all-cause and cardiovascular mortality among elderly Koreans: the Kangwha Cohort Study.韩国老年人静息心率与高血压分期对全因死亡率和心血管死亡率的影响:江华队列研究
J Geriatr Cardiol. 2016 Jul;13(7):573-9. doi: 10.11909/j.issn.1671-5411.2016.07.003.
9
Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial.奥美沙坦联用对慢性心力衰竭高血压患者的临床影响:奥美沙坦治疗稳定型心力衰竭高血压患者中血管紧张素受体阻滞剂的补充益处(SUPPORT)试验
Eur Heart J. 2015 Apr 14;36(15):915-23. doi: 10.1093/eurheartj/ehu504. Epub 2015 Jan 30.